Cargando…
Delayed Diagnosis of Congenital Combined Pituitary Hormone Deficiency including Severe Growth Hormone Deficiency in Children with Persistent Neonatal Hypoglycemia—Case Reports and Review
Apart from stimulation of human growth and cell proliferation, growth hormone (GH) has pleiotropic metabolic effects in all periods of life. Severe GH deficiency is a common component of combined pituitary hormone deficiency (CPHD). CPHD may be caused by mutations in the genes encoding transcription...
Autores principales: | Smyczyńska, Joanna, Pawelak, Natalia, Hilczer, Maciej, Lewiński, Andrzej |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9570002/ https://www.ncbi.nlm.nih.gov/pubmed/36232371 http://dx.doi.org/10.3390/ijms231911069 |
Ejemplares similares
-
Significance of Direct Confirmation of Growth Hormone Insensitivity for the Diagnosis of Primary IGF-I Deficiency
por: Smyczyńska, Joanna, et al.
Publicado: (2020) -
Thyroid function in children with growth hormone (GH) deficiency during the initial phase of GH replacement therapy - clinical implications
por: Smyczynska, Joanna, et al.
Publicado: (2010) -
Pre-treatment growth and IGF-I deficiency as main predictors of response to growth hormone therapy in neural models
por: Smyczyńska, Urszula, et al.
Publicado: (2017) -
Relationship between IGF-I Concentration and Metabolic Profile in Children with Growth Hormone Deficiency: The Influence of Children's Nutritional State as well as the Ghrelin, Leptin, Adiponectin, and Resistin Serum Concentrations
por: Stawerska, Renata, et al.
Publicado: (2017) -
Effectiveness, economical and safety aspects of growth hormone (GH) therapy in growth promoting doses in patients with isolated GH deficiency after the attainment of near-final height. Is there a need to modify the criteria of therapy withdrawal?
por: Smyczyńska, Joanna, et al.
Publicado: (2021)